MR CHONG WENG HOE
Non-Executive Chairman and Independent Director
Company / GroupThe business, the people and the ownership behind ISEC.
Business overview
ISEC Healthcare provides specialist eye care services through ophthalmic centres. Its operations include advanced eye treatments supported by specialist doctors and ophthalmic equipment, with facilities including a centre at Singapore’s Gleneagles Hospital.
Listed security
Board & management
Six Company directors and two executive officers are disclosed. Dr Wong Jun Shyan is Chief Executive Officer; Dr Fang Seng Kheong chairs the Medical Board, which is distinct from the Company board.
Non-Executive Chairman and Independent Director
Company / GroupExecutive Vice-Chairman
Company / GroupNon-Executive and Independent Director
Company / GroupNon-Executive and Non-Independent Director
Company / GroupNon-Executive and Non-Independent Director
Company / GroupNon-Executive and Non-Independent Director
Company / GroupChief Executive Officer
Company / GroupChairman of Medical Board
Group Medical BoardRoles listed in ISEC HEALTHCARE LTD. Annual Report 2025; current appointments are not independently verified.
Holdings
Direct: – shares, –%; deemed: 343,173,790(2) shares, 59.61%
As at 31 March 2026Direct: – shares, –%; deemed: 343,173,790(2) shares, 59.61%
As at 31 March 2026Direct: – shares, –%; deemed: 343,173,790(2) shares, 59.61%
As at 31 March 2026Direct: – shares, –%; deemed: 343,173,790(2) shares, 59.61%
As at 31 March 2026Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 31 March 2026 · PDF p. 125
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| DBS NOMINEES (PRIVATE) LIMITED | 381,772,147 shares; 66.31% | PDF p. 12531 March 2026 | |
| CITIBANK NOMINEES SINGAPORE PTE LTD | 49,818,578 shares; 8.65% | PDF p. 12531 March 2026 | |
| MAYBANK SECURITIES PTE. LTD. | 43,778,991 shares; 7.60% | PDF p. 12531 March 2026 | |
| CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD. | 15,725,253 shares; 2.73% | PDF p. 12531 March 2026 | |
| FANG SENG KHEONG OR CAROLINE HO MEI LI | 12,116,991 shares; 2.10% | PDF p. 12531 March 2026 | |
| JUSTIN TAN YOKE TARNG | 7,500,000 shares; 1.30% | PDF p. 12531 March 2026 | |
| SHIN HOY CHOONG | 6,301,358 shares; 1.09% | PDF p. 12531 March 2026 | |
| PHILLIP SECURITIES PTE LTD | 5,912,470 shares; 1.03% | PDF p. 12531 March 2026 | |
| LIM SIEW GEOK | 5,523,358 shares; 0.96% | PDF p. 12531 March 2026 | |
| MICHAEL LAW SIE HAUR | 4,154,378 shares; 0.72% | PDF p. 12531 March 2026 | |
| YONG KED SHEONG | 3,501,320 shares; 0.61% | PDF p. 12531 March 2026 | |
| LEE YENG FEN | 2,919,581 shares; 0.51% | PDF p. 12531 March 2026 | |
| LEE PENG HWA | 2,841,679 shares; 0.49% | PDF p. 12531 March 2026 | |
| RAFFLES NOMINEES (PTE.) LIMITED | 2,779,052 shares; 0.48% | PDF p. 12531 March 2026 | |
| WOI YOU WAN | 2,761,679 shares; 0.48% | PDF p. 12531 March 2026 | |
| SIOW YUN CHING | 2,579,774 shares; 0.45% | PDF p. 12531 March 2026 | |
| UNITED OVERSEAS BANK NOMINEES (PRIVATE) LIMITED | 2,110,800 shares; 0.37% | PDF p. 12531 March 2026 | |
| CHENG HENG LIANG | 2,100,793 shares; 0.36% | PDF p. 12531 March 2026 | |
| UOB KAY HIAN PRIVATE LIMITED | 1,946,153 shares; 0.34% | PDF p. 12531 March 2026 | |
| TAN SIOW WEI | 1,726,049 shares; 0.30% | PDF p. 12531 March 2026 | |
Group structure
All22subsidiaries are retained with the direct/indirect holding hierarchy, original ownership proportions and principal places of business. The three50%* interests carry the disclosed control condition50.0% plus1ordinary share. Seremban is a newly incorporated72%-owned indirect subsidiary with a prior-year dash.
| Company | Market | Ownership interest |
|---|---|---|
| ISEC Sdn. Bhd. (“ISEC KL”)Held directly by the Company; original proportion of ownership interestPDF p. 95 | Malaysia; ownership interest FY2025 / FY2024: 100; 100 | |
| ISEC Eye Pte. Ltd.Held directly by the Company; original proportion of ownership interestPDF p. 95 | Singapore; ownership interest FY2025 / FY2024: 100; 100 | |
| International Specialist Eye Centre Pte. Ltd.Held directly by the Company; original proportion of ownership interestPDF p. 95 | Singapore; ownership interest FY2025 / FY2024: 100; 100 | |
| ISEC Global Pte. Ltd.Held directly by the Company; original proportion of ownership interestPDF p. 95 | Singapore; ownership interest FY2025 / FY2024: 100; 100 | |
| JL Medical (Bukit Batok) Pte. Ltd.Held directly by the Company; original proportion of ownership interestPDF p. 95 | Singapore; ownership interest FY2025 / FY2024: 100; 100 | |
| JL Medical (Sembawang) Pte. Ltd.Held directly by the Company; original proportion of ownership interestPDF p. 95 | Singapore; ownership interest FY2025 / FY2024: 100; 100 | |
| JL Medical (Woodlands) Pte. Ltd.Held directly by the Company; original proportion of ownership interestPDF p. 95 | Singapore; ownership interest FY2025 / FY2024: 100; 100 | |
| JL Medical (Yew Tee) Pte. Ltd.Held directly by the Company; original proportion of ownership interestPDF p. 95 | Singapore; ownership interest FY2025 / FY2024: 100; 100 | |
| ISEC (Penang) Sdn. Bhd. (“ISEC Penang”)Held through ISEC KL; original proportion of ownership interestPDF p. 95 | Malaysia; ownership interest FY2025 / FY2024: 100; 100 | |
| ISEC (Sibu) Sdn. Bhd.Held through ISEC KL; original proportion of ownership interestPDF p. 95 | Malaysia; ownership interest FY2025 / FY2024: 55; 55 | |
| Southern Specialist Eye Centre Sdn. Bhd.Held through ISEC KL; original proportion of ownership interestPDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 100; 100 | |
| Indah Specialist Eye Centre Sdn. Bhd.Held through ISEC KL; original proportion of ownership interestPDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 100; 100 | |
| ISEC (Kuching) Sdn. Bhd.Held through ISEC KL; original proportion of ownership interestPDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 51; 51 | |
| IE Centre Sdn. Bhd.Held through ISEC KL; original proportion of ownership interestPDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 100; 100 | |
| Kampar Eye Sdn. Bhd.Held through ISEC KL; original proportion of ownership interestPDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 100; 100 | |
| ME Centre Sdn. Bhd.Held through ISEC KL; original proportion of ownership interest; control obtained by50.0% plus1ordinary share as disclosed in footnote*PDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 50*; 50* | |
| TE Centre Sdn. Bhd.Held through ISEC KL; original proportion of ownership interest; control obtained by50.0% plus1ordinary share as disclosed in footnote*PDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 50*; 50* | |
| Taiping Eye Sdn. Bhd.Held through ISEC KL; original proportion of ownership interest; control obtained by50.0% plus1ordinary share as disclosed in footnote*PDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 50*; 50* | |
| ISEC (Klang) Sdn. Bhd.Held through ISEC KL; original proportion of ownership interestPDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 58; 65 | |
| ISEC (Seremban) Sdn. Bhd.Held through ISEC KL; original proportion of ownership interest; incorporated29April2025; current72%-owned indirect subsidiary; comparative dash retainedPDF p. 96 | Malaysia; ownership interest FY2025 / FY2024: 72**; – | |
| ISEC Myanmar Company LimitedHeld through ISEC Global Pte. Ltd.; original proportion of ownership interestPDF p. 97 | Myanmar; ownership interest FY2025 / FY2024: 51; 51 | |
| ISEC Specialist Eye Clinic (Melaka) Sdn. Bhd.Held through SSEC; original proportion of ownership interestPDF p. 97 | Malaysia; ownership interest FY2025 / FY2024: 100; 100 | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dr Wong Jun Shyan | CEO | Group | PDF p. 32 |
| MS ELYSE LOW | CHIEF FINANCIAL OFFICER | Group | PDF p. 16 |
| Dr Fang Seng Kheong | Medical Board Chairman | Group | PDF p. 33 |
| Dr Robert Yeo Kim Chuan | Malacca Centre Director | Group | PDF p. 33 |
| Dr Choong Yee Fong | Kuala Lumpur Centre Director | Group | PDF p. 33 |
| Dr Alan Ang Jin Soon | Penang Centre Director | Group | PDF p. 33 |
| Dr Shin Hoy Choong | Ipoh Centre Director | Group | PDF p. 33 |
| Yoo Loo Ping | Company Secretary | Company | PDF p. 131 |
Extracted from ISEC HEALTHCARE LTD. Annual Report 2025 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| INTERESTED PERSON TRANSACTIONS (“IPT”) | There were no IPTs with value of or more than S$100,000 transacted for FY2025. | Group, FY2025 | PDF p. 45 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| NO. OF NON-DOCTOR EMPLOYEES | 366 count | Group, non-doctor employees as at 31 December 2025 · As at 2025-12-31 | PDF p. 3 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Chong Weng Hoe | 70 $'000 | Director, FY2025, Total Remuneration | PDF p. 32 |
| Wee Kim Lin Evelyn | 50 $'000 | Director, FY2025, Total Remuneration | PDF p. 32 |
| Dr Lee Hung Ming | 2,879 $'000 | Executive Director, FY2025, Total Remuneration | PDF p. 32 |
| Dr Wong Jun Shyan | 1,453 $'000 | CEO, FY2025, Total Remuneration | PDF p. 32 |
| Chen Bang | – $'000 | Director, FY2025, Total Remuneration | PDF p. 32 |
| In aggregate, the total remuneration paid to the top five (5) Key Management Personnel (who are not Directors) | S$4,840,000 | Top five Key Management Personnel (not Directors), FY2025 | PDF p. 33 |
Extracted from ISEC HEALTHCARE LTD. Annual Report 2025 and checked against the cited pages; see the original report for full context.
Corporate information